Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II).

Rosowsky, A; Wright, J E; Cucchi, C A; Flatow, J L; Trites, D H; Teicher, B A; Frei, E

Rosowsky, A; Wright, J E; Cucchi, C A; Flatow, J L; Trites, D H; Teicher, B A; Frei, E.

Affiliation

Rosowsky A; Dana-Farber Cancer Institute, Boston, Massachusetts 02115.

Cancer Res ; 47(22): 5913-8, 1987 Nov 15.

Article in En | MEDLINE | ID: mdl-3664492

Subject(s)

Carcinoma, Squamous Cell/pathology; Cisplatin/toxicity; Head and Neck Neoplasms/pathology; Methotrexate/toxicity; Biological Transport; Cell Survival/drug effects; Cells, Cultured; Drug Resistance; Humans; Methotrexate/metabolism; Phenotype

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Methotrexate / Cisplatin / Head and Neck Neoplasms Limits: Humans Language: En Journal: Cancer Res Year: 1987 Type: Article

Search on Google

XML

PubMed Links